198 related articles for article (PubMed ID: 7007281)
1. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?].
Breddin K; Loeliger EA
Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281
[No Abstract] [Full Text] [Related]
2. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Rühle H
Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
[No Abstract] [Full Text] [Related]
3. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments in favor of aggregation inhibitors].
Walter E; Weber E
Internist (Berl); 1980 Jul; 21(7):387-9. PubMed ID: 7007276
[No Abstract] [Full Text] [Related]
4. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments against aggregation inhibitors].
Reuter HD
Internist (Berl); 1980 Jul; 21(7):390-2. PubMed ID: 7007277
[No Abstract] [Full Text] [Related]
5. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Thiele R
Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
[No Abstract] [Full Text] [Related]
6. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
Breddin K
Internist (Berl); 1980 Jul; 21(7):394-6. PubMed ID: 7007279
[No Abstract] [Full Text] [Related]
7. [Summary: Aggregation inhibitors in the prophylaxis of myocardial infarct].
Walter E; Weber E; Reuter HD
Internist (Berl); 1980 Jul; 21(7):393. PubMed ID: 7007278
[No Abstract] [Full Text] [Related]
8. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Schröder R
Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
[No Abstract] [Full Text] [Related]
9. [Second prevention following myocardial infarct].
Burkart F
Schweiz Med Wochenschr; 1984 Jan; 114(3):104-7. PubMed ID: 6142527
[TBL] [Abstract][Full Text] [Related]
10. [Secondary prevention following myocardial infarct].
Follath F
Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1177-80. PubMed ID: 2877482
[No Abstract] [Full Text] [Related]
11. Aspirin after thrombolysis for MI.
Seaton TL
J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
[No Abstract] [Full Text] [Related]
12. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
Darius H; Erbel R; Belz GG; Meyer J
Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
[No Abstract] [Full Text] [Related]
13. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
[TBL] [Abstract][Full Text] [Related]
14. [Secondary prevention following a myocardial infarct].
Enjalbert M; Théroux P; Bourassa MG
Union Med Can; 1983 Mar; 112(3):219-20, 225-8, 234. PubMed ID: 6134369
[No Abstract] [Full Text] [Related]
15. [Anticoagulants or thrombocyte aggregation inhibitors in the prevention of recurrent heart infarction?].
Volger E; Theiss W
MMW Munch Med Wochenschr; 1983 Apr; 125(14):285-8. PubMed ID: 6406866
[No Abstract] [Full Text] [Related]
16. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
Spitzer W; Durst OE; Lang E
Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
Poliwoda H; Avenarius HJ
Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies after successful thrombolysis in acute myocardial infarction.
Ramsden CS
Heart Lung; 1988 Nov; 17(6 Pt 2):777-82. PubMed ID: 2973449
[No Abstract] [Full Text] [Related]
19. [Long-term antithrombotic treatment in coronary disease].
Hodara M; Samama M
J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
[TBL] [Abstract][Full Text] [Related]
20. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of anticoagulation].
Loeliger EA
Internist (Berl); 1980 Jul; 21(7):397-8. PubMed ID: 7007280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
